After the failure of multiple drug trials the outlook for an Alzheimer’s drug is bleak. This shouldn’t be a surprise. We don’t know the cause or even how to diagnose the disease.
- Professor of Medicine, Dartmouth College
When you send off a cheek swab to one of the private genome companies, you may sacrifice not just your own privacy but that of your family and your ancestors.
Theranos has had medical laboratory experts scratching their heads for some time. What the company was promising just didn’t make a lot of sense.
Even if we could develop a test or a screening process to find a pilot who would intentionally crash a plane, and that system was very, very good, virtually all positives would be false positives.
Contact Norman for
- General
- Media request
- Speaking request
- Consulting / Advising
- Research collaboration
- Research supervision
- Location: Hanover, NH, USA
- Article Feed
- Joined
